Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

McKesson : UBS Adjusts McKesson's Price Target to $210 From $200, Maintains Buy Rating

04/19/2021 | 10:11am EDT


© MT Newswires 2021
All news about MCKESSON CORPORATION
06/23GLOBAL MARKETS LIVE : Microsoft, Morgan Stanley, Heineken, Twitter, AstraZeneca...
06/22BRIDGEBIO PHARMA  : TRUSELTIQ FDA Approved for Treatment of Cholangiocarcinoma A..
AQ
06/21MCKESSON  : TRUSELTIQ (infigratinib), FDA Approved for Treatment of Cholangiocar..
PU
06/11MCKESSON  : LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutate..
PU
06/08MCKESSON  : 2021 Annual Meeting of Shareholders and Proxy Statement
PU
06/08MCKESSON  : 2021 Annual Report
PU
06/08Amazon Pharmacy offers half-yearly prescriptions starting at $6
RE
06/07CORRECTION : Mizuho Securities Maintains Price Target for McKesson at $205, Reit..
MT
06/07MCKESSON  : Mizuho Securities Adjusts McKesson PT to $190 From $205, Maintains N..
MT
06/03MCKESSON  : Insider Sale at McKesson (MCK) Continues Selling Trend
MT
More news
Financials (USD)
Sales 2022 249 B - -
Net income 2022 2 717 M - -
Net Debt 2022 539 M - -
P/E ratio 2022 10,9x
Yield 2022 0,93%
Capitalization 29 206 M 29 206 M -
EV / Sales 2022 0,12x
EV / Sales 2023 0,11x
Nbr of Employees 67 500
Free-Float 57,3%
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 188,83 $
Average target price 222,93 $
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Britt J. Vitalone Chief Financial Officer & Executive Vice President
Edward A. Mueller Independent Chairman
Nancy Flores Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION8.57%29 206
WALGREENS BOOTS ALLIANCE, INC.30.59%44 750
JD HEALTH INTERNATIONAL INC.-29.60%42 068
CARDINAL HEALTH, INC.5.08%16 448
HUADONG MEDICINE CO., LTD72.63%12 452
SINOPHARM GROUP CO., LTD.24.34%9 141